Friday, October 28, 2016 9:39:03 AM
http://bhcourier.com/beverly-hills-film-exec-pledges-1-millon-ucla-neurosurgery-brain-cancer-research/
Film executive Ted Gagliano (Beverly Hills, Calif.) has committed $1 million to support the UCLA Department of Neurosurgery’s brain cancer research. As president of post-production at 20th Century Fox Studios, he has helped guide more than 500 films to the big screen during his 30-year career, including box-office blockbusters like “Avatar” and “Titanic.”
“We are deeply grateful to Mr. Gagliano for his compassion and farsighted vision,” said Dr. Neil Martin, chairman of neurosurgery at the David Geffen School of Medicine at UCLA. “His generous gift will enable the UCLA Department of Neurosurgery to pioneer new approaches to fighting aggressive brain cancer and enable more patients to lead longer lives.”
In an unexpected twist of fate, Gagliano was invited by a colleague to attend UCLA Neurosurgery’s 2011 Visionary Ball the same night that one of his closest friends was undergoing surgery to remove a glioblastoma, a fast-growing, lethal brain tumor. During the dinner gala, a patient at each table stood up and shared how a UCLA neurosurgeon had saved his or her life.
“The survivors’ personal stories of hope and courage really inspired me,” Gagliano recalled. “I was moved by the unfairness of brain disease, and it hit me how lucky I am to be healthy. I learned about the great work that UCLA does and wanted to do more to help.”
A tour of researcher Dr. Linda Liau’s laboratory helped seal Gagliano’s commitment. Her team has developed a novel vaccine that trains a patient’s immune system to recognize and destroy brain cancer cells, adding years to the patient’s life.
“Seeing my name on a building isn’t my thing,” Gagliano said. “What excites me is the chance to offer cancer patients a promising treatment that gives them hope and makes their lives better. That’s why I was fascinated by Dr. Liau’s vaccine work. She isn’t just surgically removing brain tumors; she’s looking for new ways to stop them in their tracks for good. I wanted to support research that she wouldn’t be able to do otherwise.”
The funds from Gagliano’s pledge will allow Liau to test a new approach that boosts the vaccine’s impact by strengthening the immune system.
“Mr. Gagliano’s generous support will enable my team to take a significant step forward in improving personalized therapies to fight glioblastoma,” said Liau, vice chair of neurosurgery and director of the UCLA Brain Tumor Program. “We are exploring new research advances and launching clinical trials that we hope will work better in keeping patients cancer-free longer.”
Pledging $1 million to support research was just Gagliano’s first step toward making a difference in brain cancer patients’ lives. Earlier this year, he joined the UCLA Department of Neurosurgery’s board of advisers and hosted the first annual Golden Portal Awards. Benefiting UCLA’s Brain Tumor Program, the event pays tribute to excellence in film and science.
In recognition of Gagliano’s personal contributions, the UCLA Department of Neurosurgery will present him with its prestigious Luminary Award at its 2012 Visionary Ball at the Beverly Wilshire Hotel on Oct. 25. (More info at http://neurosurgery.ucla.edu/visionaryball_home.cfm?id=460)
The UCLA Department of Neurosurgery is committed to providing the most comprehensive patient care through innovative clinical programs in minimally invasive brain and spinal surgery; neuroendoscopy; neuro-oncology for adult and pediatric brain tumors; cerebrovascular surgery; stereotactic radiosurgery for brain and spinal disorders; surgery for movement disorders such as Parkinson’s disease; and epilepsy surgery. For 21 consecutive years, the department has been ranked among the top neurosurgery programs in the nation by U.S. News & World Report, including No. 1 in Los Angeles and No. 2 on the West Coast.
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM